<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320108</url>
  </required_header>
  <id_info>
    <org_study_id>ESWTbraindamage</org_study_id>
    <nct_id>NCT04320108</nct_id>
  </id_info>
  <brief_title>ESWT for Shoulder Pain in Patients With Brain Damage</brief_title>
  <official_title>The Effects of Extracorporeal Shockwave Therapy (ESWT) for Shoulder Pain in Patients With Brain Damage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bundang CHA Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bundang CHA Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy
      (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range) on
      subscapularis and lesser and greater tuberlces of humerus to reduce pain in patients with
      brain damage
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 18, 2020</start_date>
  <completion_date type="Anticipated">February 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical rating scale (NRS)</measure>
    <time_frame>Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)</time_frame>
    <description>Pain intensity (0-10, ordinal scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Shoulder Pain and Disability Index (SPADI)</measure>
    <time_frame>Up to 4 weeks (baseline, 2 weeks + 1 day, 4 weeks)</time_frame>
    <description>Scoring scale consist of 5 pain scale and 8 disability scale, in %, 0 (best) to 100 (worst)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Brain Damage, Hypoxic</condition>
  <condition>Stroke</condition>
  <condition>Brain Tumor</condition>
  <condition>ICH</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal shockwave therapy</intervention_name>
    <description>Extracorporeal shockwave therapy 6 times during 2 weeks</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Brain damaged patient confirmed in the brain image

          -  1 month after brain damage

          -  Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS)

          -  Cognitive functions that can clearly point out NRS with more than 15 points in the
             mini mental state examination (MMSE)

          -  Age: 20 and older

          -  Person who has agreed in writing to decide his or her participation and comply with
             the precautions

        Exclusion Criteria:

          -  Pain due to trauma

          -  Injection treatments two weeks before participating in the study

          -  Severe coagulopathy (excluding antiplatelet use)

          -  Impaired cognition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MinYoung Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Rehabilitation Medicine, CHA Bundang Medical Center, CHA University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MinYoung Kim, MD, PhD</last_name>
    <phone>82-30-780-6281</phone>
    <email>kmin@cha.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Rehabilitation Medicine, CHA Bundang Medical Center</name>
      <address>
        <city>Seongnam</city>
        <zip>13496</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MinYoung Kim, MD,PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 21, 2020</study_first_submitted>
  <study_first_submitted_qc>March 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>May 2, 2020</last_update_submitted>
  <last_update_submitted_qc>May 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bundang CHA Hospital</investigator_affiliation>
    <investigator_full_name>MinYoung Kim, MD, PhD</investigator_full_name>
    <investigator_title>Principal professor of Rehabilitation Medicine</investigator_title>
  </responsible_party>
  <keyword>Extracorporeal shockwave therapy</keyword>
  <keyword>Brain damage</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

